Viridian Therapeutics, Inc.\DE VRDN Insider Ownership

NASDAQ VRDN
$22.92 +0.49 (+2.18%)
As of: Oct 21, 2026 · 1:27 PM EDT

Insider Holdings by Owner

5.96Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
4.58%
▲+0.032% pp QoQ
Shares Held by Insiders
5.19Mn
filed for Sep 2026
▲+0.71% QoQ
Shares Outstanding
113.24Mn
113,238,218 shares
Direct Holdings
94.56K
Indirect: 5.09Mn
Net Shares Traded (QoQ)
+36.51K
net buying in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Over the past year, VRDN insiders bought $30 million of stock (1.63Mn shares) and sold $418,990 (16.48K shares) on the open market.

Form 4 Holdings

Insiders Holding VRDN

Insiders 8
Shares held 5.96Mn
Of outstanding 5.26%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Funds Management Llc Fairmount Director, TenPercentOwner 0 5,090,928 5,090,928 85.5% 13 May, 2026
2 Jonathan Violin Chief Executive Officer 480,905 0 480,905 8.1% 07 Feb, 2023
3 Scott Dunseth Myers Chief Executive Officer 259,500 0 259,500 4.4% 12 Apr, 2023
4 Radhika Tripuraneni Chief Medical Officer 40,000 0 40,000 0.7% 18 Aug, 2026
5 Stephen F. Mahoney President And Ceo 33,349 0 33,349 0.6% 09 Mar, 2026
6 Lara Meisner Chief Legal Officer 29,971 0 29,971 0.5% 20 Jun, 2023
7 Thomas W. Beetham Chief Operating Officer 13,361 0 13,361 0.2% 09 Mar, 2026
8 Seth Harmon Chief Financial Officer 7,850 0 7,850 0.1% 09 Mar, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

344 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
19 Aug, 2026 Jennifer Tousignant Chief Legal Officer Disposed S 4,212 $24.50 $103.19K 0 Direct
19 Aug, 2026 Jennifer Tousignant Chief Legal Officer Acquired M 10,000 $14.41 $144.10K 10,000 Direct
19 Aug, 2026 Jennifer Tousignant Chief Legal Officer Disposed S 10,000 $24.50 $245.00K 0 Direct
19 Aug, 2026 Jennifer Tousignant Chief Legal Officer Disposed M 10,000 $0.00 $0 114,072 Direct
14 Aug, 2026 Radhika Tripuraneni Chief Medical Officer Acquired M 40,000 $13.21 $528.40K 40,000 Direct
14 Aug, 2026 Radhika Tripuraneni Chief Medical Officer Disposed M 40,000 $0.00 $0 0 Direct
01 Jul, 2026 Arlene Morris Director Acquired A 32,341 $0.00 $0 32,341 Direct
01 Jul, 2026 Sarah Gheuens Director Acquired A 32,341 $0.00 $0 32,341 Direct
01 Jul, 2026 Jennifer K. Moses Director Acquired A 32,341 $0.00 $0 32,341 Direct
01 Jul, 2026 Christopher W. Cain Director Acquired A 32,341 $0.00 $0 32,341 Indirect
01 Jul, 2026 Jeffrey Robert Ajer Director Acquired A 32,341 $0.00 $0 32,341 Direct
01 Jul, 2026 Tomas Kiselak Director Acquired A 32,341 $0.00 $0 32,341 Indirect
11 May, 2026 Funds Management Llc Fairmount Director, TenPercentOwner Acquired P 1,176,470 $17.00 $20.00Mn 5,090,928 Indirect
03 Mar, 2026 Stephen F. Mahoney President And Ceo Disposed F 7,408 $30.19 $223.65K 33,349 Direct
03 Mar, 2026 Seth Harmon Chief Financial Officer Disposed F 2,031 $30.19 $61.32K 7,850 Direct
03 Mar, 2026 Thomas W. Beetham Chief Operating Officer Disposed F 3,048 $30.19 $92.02K 13,361 Direct
03 Mar, 2026 Jennifer Tousignant Chief Legal Officer Disposed F 1,675 $30.19 $50.57K 3,494 Direct
02 Mar, 2026 Radhika Tripuraneni Chief Medical Officer Acquired A 95,800 $0.00 $0 95,800 Direct
03 Mar, 2026 Thomas W. Beetham Chief Operating Officer Acquired M 9,409 — — 16,409 Direct
03 Mar, 2026 Stephen F. Mahoney President And Ceo Acquired M 18,357 — — 40,757 Direct